$PASG 4 SEC Filings

Filed On	Filing
29 Jun 2026	Form 4: Lynx1 Capital Management Lp, 10% owner and 1 other Bought 50,055 shares ($206K)
21 May 2026	Form 4: Sondhi Dolan, Director Granted 10,539 Director Stock Option (right to buy)
21 May 2026	Form 4: Porter Derrell, Director Granted 10,539 Director Stock Option (right to buy)
21 May 2026	Form 4: Kassberg Thomas Richard, Director Granted 10,539 Director Stock Option (right to buy)
21 May 2026	Form 4: Kapadia Sandip, Director Granted 10,539 Director Stock Option (right to buy)
21 May 2026	Form 4: Gowen Maxine, Director Granted 10,539 Director Stock Option (right to buy)
21 May 2026	Form 4: Countouriotis Athena, Director Granted 10,539 Director Stock Option (right to buy)
18 Mar 2026	Form 4: Borthwick Kathleen, CFO Granted 15,610 Employee Stock Option (right to buy)
18 Mar 2026	Form 4: Chou William, Director Granted 58,000 Employee Stock Option (right to buy)
12 Jan 2026	Form 4: Borthwick Kathleen, CFO Received 5,000 shares by exercise or conversion · Sold 2,062 shares ($38K)
12 Jan 2026	Form 4: Chou William, Director Received 10,000 shares by exercise or conversion · Sold 4,076 shares ($75.2K)
29 Dec 2025	Form 4: Borthwick Kathleen, CFO Granted 10,000 Restricted Stock Unit
29 Dec 2025	Form 4: Chou William, Director Granted 20,000 Restricted Stock Unit
15 Sep 2025	Form 4: Lynx1 Capital Management Lp, 10% owner and 1 other Bought 325 shares ($2.26K) · Bought 19,783 shares ($138K) · Bought 11,900 shares ($83.2K)
24 Jul 2025	Form 4: Lynx1 Capital Management Lp, 10% owner and 1 other Bought 13,123 shares ($71.3K) · Bought 49,302 shares ($283K) · Bought 66,423 shares ($379K)
26 Jun 2025	Form 4: Orbimed Advisors Llc, 10% owner and 1 other Sold 231,600 shares ($81.1K) · Sold 138,800 shares ($45.8K) · Sold 213,257 shares ($70.4K)
30 May 2025	Form 4: Kapadia Sandip, Director Granted 201,857 Director Stock Option (right to buy)
30 May 2025	Form 4: Gowen Maxine, Director Granted 201,857 Director Stock Option (right to buy)
30 May 2025	Form 4: Countouriotis Athena, Director Granted 201,857 Director Stock Option (right to buy)
30 May 2025	Form 4: Porter Derrell, Director Granted 201,857 Director Stock Option (right to buy)

Comments